Hi [[ session.user.profile.firstName ]]

Elsevier's Life Science Solutions

  • Date
  • Rating
  • Views
  • Literature searching in Health Economics
    Literature searching in Health Economics
    Julie Glanville, Associate Director at York Health Economics Consortium Recorded: Dec 3 2018 51 mins
    Please note: change of date!

    In this webinar, Julie Glanville , Associate Director at York Health Economics Consortium, will discuss literature searching in Health Economics.

    Health economics evidence is a key element in much health services research and particularly in health technology assessments. Health economic models are increasingly used to assist with health care decision making. Identifying economic evidence to inform such research can involve searches in a range of databases and using a variety of strategies.

    This webinar will summarize the key resources which can be searched to identify health economics information including economic evaluations and economic models. We will also explore how to design search strategies to find economic evaluations including economic models. With the closure of key economic evaluation databases (NHS EED and HEED) we will be focusing on how to identify economic evaluations from major bibliographic databases.

    Julie Glanville is Associate Director at York Health Economics Consortium, part of the University of York. Here, she manages systematic review and literature review projects. She also organizes the YHEC training programme.

    YHEC provides a range of research services including literature searches and evidence identification to inform research projects in healthcare topics but also in other fields such as food safety and feed safety, social care, housing, criminal justice and education. YHEC contributes to the evidence base for information retrieval with a special focus on identifying economic evidence and search filters (strategies) for a range of research methods.

    YHEC carries out systematic and non-systematic reviews for a range of clients to identify the effects of drugs, devices and other interventions. The training program also partners with Quantics Consulting to provide indirect treatment comparisons (ITCs) and mixed treatment comparisons (MTCs).
  • What's new in PharmaPendium?
    What's new in PharmaPendium?
    Pooja Jain Recorded: Nov 6 2018 64 mins
    Successful drug development requires anticipating safety and regulatory issues as early as possible. PharmaPendium is uniquely positioned to facilitate efficient translational studies of drug safety and efficacy. It supports risk assessment activities with unique access to valuable adverse event and approval documents alongside tools that maximise insights into drug safety and efficacy data.

    The 2018 development plan for PharmaPendium focused on strengthening this position as a support tool for early assessments of drug candidates.

    About this webinar
    Join PharmaPendium Product Manager Pooja Jain to discover the new features that facilitate efficient translational studies of drug safety and efficacy, including:

    - New search and filter capabilities that enable users to specifically search for pharmacokinetic, metabolizing enzyme and transporter data for concomitant drugs and other substances
    - Improvements to PharmaPendium’s unique FDA Adverse Event Reporting System (FAERS) search functionality, including a heatmap and percentage calculator, which make it easier to visualize and compare differences in adverse event reporting
    - Updates to the Drug–Drug Indication Risk Calculator (DDIRC) content to keep pace with user needs for drug–drug interaction (DDI) risk prediction
    - Updates to the MedDRA (Medical Dictionary for Regulatory Activities) taxonomy, which helps ensure that searches conform to the clinically validated international nomenclature used by regulatory authorities
    -Improvements to the Indications taxonomy and search capabilities that provide insight into approved vs tested/off-label indications
    - Email alerts to help users stay up to date on new content relevant for a given search

    The webinar includes demonstrations of all the new features and a Q&A session for attendees to get further information about PharmaPendium’s drug safety and efficacy workflows.
  • Introducing Embase French Local Literature Module
    Introducing Embase French Local Literature Module
    Iveta Petrova, Embase Product Manager Recorded: Oct 31 2018 47 mins
    Literature is one of the essential sources to identify high quality ADR reports. Regulatory authorities require companies to monitor major international publications through databases, as well as local, non-English content sources in each of the countries where the drugs are marketed. Currently, the local, non-English content sources is not available in most international literature databases, therefore screening, reviewing and monitoring this type of literature costs extra time, money and creates an additional compliance risk.

    In this webinar, Embase product manager Iveta Petrova will discuss:
    -The challenges in Local Literature Monitoring process for pharmacovigilance, with a focus on the French market
    -The concepts of Embase French Local Literature Module
    -How to use this module in Embase.com to build effective searches to identify the mention of drugs and ADRs in French journals

    About the speaker:
    Iveta Petrova holds a Ph.D. from Leiden University for research done on Wnt signaling in the nervous system. She joined the Embase team at Elsevier as part of the Content quality department. For 2 years she was responsible for writing and updating the indexing guidelines, as well as monitoring the quality of indexing. One year ago she joined the Product management team of Embase. Currently her tasks include continuous engagement with customers and market research to further improve and develop tools to support them in their daily responsibilities, specifically the enhancement of evidence-based medicine, pharmacovigilance and medical device clinical evaluation and safety.
  • Enhancing key PV Solutions to boost the efficiency of drug safety workflows
    Enhancing key PV Solutions to boost the efficiency of drug safety workflows
    Sherry Winter, Senior Solution Marketing Manager at Elsevier Recorded: Oct 23 2018 51 mins
    Databases of peer-reviewed biomedical literature and regulatory documents are crucial sources for pharmacovigilance activities. When monitored properly, they yield drug safety signals that are essential for risk–benefit assessments and adverse event reports. However, both are vast resources that can be challenging to monitor efficiently and accurately, especially if different interfaces are needed to access each database.

    In 2018, Elsevier is enhancing key solutions for pharmaceutical R&D as part of ongoing efforts to improve the comprehensiveness, efficiency, accuracy and compliance of pharmacovigilance-focused research. By ensuring that all relevant information is captured efficiently, the company is helping drug safety and pharmacovigilance teams deliver considerable improvements in health-critical workflows.

    This webinar focuses on 2018 enhancements to Embase, PharmaPendium and QUOSA PV, showing how each solution offers dedicated means to boost the efficiency and accuracy of the monitoring of relevant databases, assessment of captured information, and supervision of the workflow. These enhancements include:
    - A dedicated Embase query form for efficient creation and validation of the complex search strings needed for high-recall, high-precision literature searching
    - An Embase French Local Language Module to extend the reach of Embase into specially selected French-language literature
    - More capabilities in PharmaPendium for searching the FDA Adverse Event Reporting System (FAERS)
    - Even more flexible means to run and oversee GxP-compliant workflows through QUOSA PV, with new functionalities for medical review, signal management and quality assurance. The webinar will address these solutions and enhancements in the context of comprehensive support for the goals of pharmacovigilance.
  • Searching for adverse effects of medical devices in MEDLINE and Embase
    Searching for adverse effects of medical devices in MEDLINE and Embase
    Dr Su Golder NIHR Research Fellow, Health Sciences, University of York Recorded: Oct 18 2018 44 mins
    In this webinar, Dr Su Golder NIHR Research Fellow, Health Sciences, at the University of York will discuss:

    - Importance of medical device adverse effects
    - Problems with searching for medical device adverse effects
    - Approaches to searching for medical device adverse effects
    - Research into search filters for medical device adverse effects

    Dr Su Golder is a qualified information specialist with over 20 years' experience. She has worked in lots of different settings and has a wide breadth of experience in supporting systematic reviews of healthcare interventions. She has specialist expertise in systematic review methodology and systematic reviews of adverse effects and has taught in this field. Her PhD on optimising the retrieval of adverse effects data was funded by the MRC and has made an important contribution to the retrieval of information on adverse effects both nationally and internationally. Her current research is on the use of unpublished data, text mining and social media to maximise the efficiency and effectiveness of the retrieval of adverse effects data and has been funded by the National Institute for Health Research (NIHR) and began in January 2015 on a part-time basis.
  • Improved Synthetic Planning with Reaxys Procurement Integration- 5pm CET
    Improved Synthetic Planning with Reaxys Procurement Integration- 5pm CET
    Scott Hutton, Commercial Director and Prima Sung, Sr. Solution Marketing Manager Recorded: Oct 17 2018 50 mins
    Laboratory scientists face many practical challenges in implementing a desired chemical synthesis. One major challenge is the ability to access accurate information on what starting materials are available in a company’s local inventory, as well as which suppliers may be used to purchase desired chemicals. Once materials are identified, how long will it take to get them? What is the company’s negotiated price for each material?

    Besides being clever scientists, medicinal chemists must be master logistics planners coordinating all the materials and documentation necessary to perform chemical synthesis on an ongoing basis. Elsevier understands the chemist’s synthetic work flow and has taken steps with Reaxys to enable integration with local chemical inventory and purchasing systems.

    Please join us for this webinar, in which we will focus on:

    - The challenges of identifying and purchasing critical starting materials for chemical synthesis planning
    - How your procurement system can be integrated with Reaxys to make this process easier while saving the organization time and money.
    - How additional data from your systems can be integrated with Reaxys to improve workflows and accelerate discovery.
  • Improved Synthetic Planning with Reaxys Procurement Integration - 9am CET
    Improved Synthetic Planning with Reaxys Procurement Integration - 9am CET
    Scott Hutton, Commercial Director and Prima Sung, Sr. Solution Marketing Manager Recorded: Oct 17 2018 45 mins
    Laboratory scientists face many practical challenges in implementing a desired chemical synthesis. One major challenge is the ability to access accurate information on what starting materials are available in a company’s local inventory, as well as which suppliers may be used to purchase desired chemicals. Once materials are identified, how long will it take to get them? What is the company’s negotiated price for each material?

    Besides being clever scientists, medicinal chemists must be master logistics planners coordinating all the materials and documentation necessary to perform chemical synthesis on an ongoing basis. Elsevier understands the chemist’s synthetic work flow and has taken steps with Reaxys to enable integration with local chemical inventory and purchasing systems.

    Please join us for this webinar, in which we will focus on:

    - The challenges of identifying and purchasing critical starting materials for chemical synthesis planning
    - How your procurement system can be integrated with Reaxys to make this process easier while saving the organization time and money.
    - How additional data from your systems can be integrated with Reaxys to improve workflows and accelerate discovery.
  • Librarians’ Role in Evidence-Based Medicine Education for Healthcare Policymaker
    Librarians’ Role in Evidence-Based Medicine Education for Healthcare Policymaker
    Maylene Qiu, Systematic Review Coordinator and Clinical Liaison Librarian at Biomedical Library, University of Pennsylvania Recorded: Sep 19 2018 54 mins
    NOTE: NEW DATE!

    The practice of evidence-based medicine (EBM) requires retrieving the knowledge from ever-increasing volume of literature. Librarians have supported EBM by offering information searching skills and various tailored training programs.

    While users’ needs constantly drive library’s teaching activities, customizable EBM teaching modules have been developed to respond to different needs of library's constituencies, particularly the policy makers within a university’s healthcare system. This involvement creates a new avenue to convey library’s value.

    About the speaker Maylene Qiu

    Maylene is responsible for developing and providing systematic review services for the patrons principally from the health sciences schools at UPenn and the UPenn Healthcare System. She also serves as the Clinical Liaison Librarian promoting evidence-based medicine information resources and services.

    Before coming to Penn, Maylene was Clinical Reference Librarian at Quillen College of Medicine Library at East Tennessee State University, where she provided services for the clinicians at the Point-of-Care.

    Prior to the library field, she has 10-year experience in pharmaceutical science obtained from working in China, Japan, and Canada. In that career, she commercialized several products in nutrition and agriculture. She earned a B.S. in Pharmaceutical Science from the Nanjing University of Chinese Traditional Medicine, and an M.A. in the Library and Information Science from the University of Wisconsin – Madison.
  • Evidence-Based Searching and Reporting the Search for Systematic Reviews
    Evidence-Based Searching and Reporting the Search for Systematic Reviews
    Farhad Shokraneh, University of Nottingham Recorded: Aug 22 2018 63 mins
    Search methods are part of the research methods in systematic reviews and evidence synthesis. Running a robust search requires following the existing evidence in selection of databases and search filters, addition of limitations, and inclusion of a search methodologist in your team. While a proper evidence-based search protocol could reduce waste and increase value in systematic reviewing, proper reporting should make your search a piece of science.

    The search methods should be reported in a way that anyone who have access to the databases could repeat the search strategies and search methods (reproducibility) and retrieve the same or very similar search results both in terms of content and numbers (replicability). Following the minimum requirement for reporting the search, the team could produce an evidence-based search method that could be re-used by the readers. The team could also share the search results, as part of their research data, to prevent duplicate efforts for the researchers who want to update the review.

    About Speaker:
    Farhad Shokraneh studied Medical Library and Information Science for seven years and was a clinical librarian in an emergency department for a short time. He worked as a research fellow in Research Center for Pharmaceutical Nanotechnology for two years. Farhad later joined Cochrane Schizophrenia Group in University of Nottingham to manage the largest database of schizophrenia trials and to update over 320 Cochrane reviews. He is also a volunteer with 14 Cochrane groups.

    He ran his first systematic review search in 2004 and continued providing search and consultancy services to academic, clinical and policy making teams around the world for over 2,000 grant applications, clinical trials, economic evaluations, rapid reviews, scoping reviews, umbrella reviews, systematic reviews, overviews, health technology assessments, and clinical practice guidelines.
  • Introduction to PharmaPendium: Leveraging FDA and EMA drug approval data
    Introduction to PharmaPendium: Leveraging FDA and EMA drug approval data
    Sherry Winter, PhD Recorded: Jul 11 2018 56 mins
    NOTE the date change.
    Learn how comparative information from FDA and EMA drug approval documents supports critical drug development decisions

Embed in website or blog